Dolutegravir Monotherapy's Virological Efficacy in a Highly Treatment-Experienced Patient

AIDS Res Hum Retroviruses. 2019 Apr;35(4):359-360. doi: 10.1089/AID.2018.0117. Epub 2019 Jan 22.

Authors

Massimiliano Lanzafame¹, Emanuela Lattuada², Sebastiano Rizzardo², Daniela Piacentini², Sheila Chiesi², Romualdo Mazzi²

Affiliations

¹ 1 "Diagnosis and Therapy of HIV Infection" Unit, G.B. Rossi University Hospital, Verona, Italy.
² 2 Infectious Diseases Unit, G.B. Rossi University Hospital, Verona, Italy.

PMID: 30525872
DOI: 10.1089/AID.2018.0117

No abstract available

Publication types

Letter
Comment

MeSH terms

Communication
HIV Infections*
HIV Integrase Inhibitors*
Heterocyclic Compounds, 3-Ring
Humans
Integrases
Oxazines
Patients
Piperazines
Pyridones
Reverse Transcriptase Inhibitors

Substances

HIV Integrase Inhibitors
Heterocyclic Compounds, 3-Ring
Oxazines
Piperazines
Pyridones
Reverse Transcriptase Inhibitors
dolutegravir
Integrases